Skip to main content
. 2013 Dec 18;13:210. doi: 10.1186/1471-2431-13-210

Table 4.

Differences in antipyretics use in participants in the 2009 (n = 480) and/or in the 2012 (n = 300) survey, and who were aware (n = 168) or not aware (n = 132) of the IFG

  Participants in 2009 survey n (%) Participants in 2012 survey n (%) P Participants in 2012 survey who were aware of the IFG n (%) Participants in 2012 survey who were not aware of the IFG n (%) P
First choice antipyretic drug
Acetaminophene
463 (96.4)
295 (98.3)
0.188
167 (99.4)
128 (97.0)
0.23
Ibuprofene
17 (3.6)
4 (1.3)
0.104
0
4 (3.0)
0.083
Aspirin
0 (0.0)
0 (0.0)
 
0
0
 
Other (metamizole. betamethasone)
0 (0.0)
1 (0.4)
0.812
1 (0.6)
0
0.904
Second choice antipyretic drug
Acetaminophene
32 (6.7)
19 (6.3)
0.973
7 (4.2)
12 (9.1)
0.134
Ibuprofene
440 (91.6)
276 (91.0)
0.975
159 (94.6)
117 (88.6)
0.091
Aspirin
1 (0.3)
2 (0.7)
0.681
0 (0.0)
2 (1.5)
0.376
Other (metamizole. betamethasone)
7 (1.4)
3 (1.0)
0.821
2 (1.2)
1 (0.8)
0.833
Alternating use of antipyretic drugs and use of atipyretic according to child’s discomfort
Yes
130 (27.0)
34 (11.3)
≤0.0001
12 (7.0)
22 (17.0)
0.016
No
350 (72.9)
266 (88.7)
≤0.0001
156 (93.0)
110 (83.0)
0.000
Use of physical methods
With antipyretic drug
62 (13.0)
29 (9.6)
0.207
11 (6.5)
18 (14)
0.062
Before the antipyretic drug
15 (3.3)
9 (3.0)
0.909
2 (1.2)
7 (5.0)
0.083
If the fever persists
315 (65.0)
153 (51.0)
≤0.0001
71 (42.3)
82 (62.0)
0.000
No never 88 (18.7) 109 (36.4) ≤0.0001 84 (50.0) 25 (19.0) 0.000